arrow
H

Hirotaka Tomiyasu

The University of Tokyo
H指数:17
被引数:926

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of Novel Therapeutic Agent Candidates Through High Throughput Screening With Chemical Library Based on Molecular Subclassification in Canine Histiocytic Sarcoma Cell Lines

通过基于犬组织细胞肉瘤细胞系的分子亚分类,利用化学文库进行高通量筛选以鉴定新型治疗剂候选物

2026-09-010
OAAI
Characterization of putative germline pathogenic variants in 27 candidate cancer-predisposing genes in 813 cats using a feline-specific multiplex targeted sequencing

利用猫特异性多重靶向测序技术对813只猫中27个候选癌症易感基因的潜在生殖系致病性变异进行表征

2026-08-080
OA
Genetic variants of flavin-containing monooxygenase (FMO) 1 and FMO3 in 5887 dogs influenced oxygenations of probe substrates benzydamine, trimethylamine, and methyl p-tolyl sulfide

5887只狗中,黄素单加氧酶(FMO)1和FMO3的遗传变异影响了探针底物苯茚胺、三甲胺和对甲苯硫醚的氧化反应。

2026-02-100
PRE
In response to 'Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study' by Treggiari et al.

作为Treggiari等人发表的题为“Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study”的论文的回应。

2025-11-010
PRE
Genetic variants in dog cytochrome P450 2B6 and their relevance to inter-individual variability of oxidations of probe drug propofol

犬细胞色素P450 2B6的遗传变异及其与探针药物丙泊酚氧化反应个体间变异的相关性

2025-10-300
PRE
Genetic variants of cytochrome P450 2C21 identified by screening 6344 dogs influenced oxidations of the probe drug omeprazole

通过筛查6344只狗,鉴定出的细胞色素P450 2C21基因变异体影响了探针药物奥美拉唑的氧化作用。

2025-10-030
PRE
Whole exome and transcriptome analysis revealed the activation of ERK and Akt signaling pathway in canine histiocytic sarcoma
2023-05-255
OAAI
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning
2021-12-016
OAAI